| Micro-channel |
 |
|
|
|
|
|
| |
| The bargaining power of medical couplet begins to prevail, the enterprise scoop the inside scoop: the pain is untenable! |
| |
| Author：中國銘鉉 企劃部 Release Time：2017-8-31 10:17:02 Number Browse：771 |
| |
The medical network on August 31, the medical association accelerated to the ground, "the second bargaining" also began to prevail.In many places, it is also explicitly proposed to encourage the price negotiation of medical interconnection in medical consumables.
But the "second price" is more obscure than the gory haggling.Recently, a number of pharmaceutical people have reported to cypress blue, expecting to attract attention.
The second price negotiation is from prohibition to opening
Promulgated by the state council on February 9, article 9 of the "opinions", "allow public hospital in the provincial drug centralized purchasing platform (provincial public resources trading platform) combined with quantity, purchasing budget."
Industry insiders believe that this means that the "ban" on the "second price of hospital procurement of drugs" at the national policy document level is open, and that drug prices are also inevitable.
However, there is a major breakthrough in the opinion, which is to make it clear: "improve the procurement mechanism of drugs.Payment in fully implementing health care reform or established medicare drug payment standard, allowing public hospital in the provincial drug centralized purchasing platform (provincial public resources trading platform) combined with quantity, purchasing budget."
In the past years, in the aspect of national policy documents "prohibit hospitals purchasing drugs secondary bargaining", such as "WeiGui wealth hair [2010] no. 2010" file "about specifications issued by the medical institutions and drug centralized purchasing work notice mentioned that medical institutions in accordance with the contract selling drugs," secondary bargaining "should not be conducted.To strictly check the purchase invoice of drugs, to prevent outsourcing, purchase or purchase drugs from non-prescribed channels.
The pharmaceutical companies see the second price
A few days ago, cypress blue is in charge of the director of the drug company that participates directly in the second price of the second price of the charge of the charge of the company, everybody revealed a lot of inside information.
"The second price negotiation in some areas is actually a second bid," said a drug company leader.In the head's view, the so-called second price is a secondary tender for the "1 + X" model of a large hospital plus a few small hospitals.
Speaking of joint procurement by the medical association, the head shook his head, saying that the process of negotiations between pharmaceutical companies and medical bodies was overwhelmed and untenable.
Behind the couplet of medical procurement market rule is "take quantity procurement", by rights with large amount of price low price discrimination laws, but in the process of the actual practice, a number of drug companies, said an official with the enterprise product price drop down again, expect sales of have no cash.
In the process of the second price negotiation, the enterprises often encounter the same subject multiple price negotiation, the different principal rotation bargaining.A province or city, for example, might make up a dozen or even dozens of medical groups, all of which have to negotiate with the company.The drug companies' departments must constantly expand to cope with such a large number of mediators, and even so, the companies involved are struggling to survive.
In addition, the medical couplet body no matter size, can to enterprise product prices quoted for the current starting point for negotiation, so that enterprise product price seems to be in the process of "infinite tend to be 0", drug companies, head of ridicule.
Once negotiated, a more substantial reduction in the price of the company's products in subsequent negotiations will often result in a unilateral destruction of the contract and a request for renegotiation.The price of a company's products is often difficult to keep secret during the bargaining process.
A drug firms regional marketing head to match the blue parker said that a rather helplessly, and enterprise in the process of negotiations and medical couplet body, hands without any credentials, negotiations, as a fingerprint leave, the hospital party once tore up the contract, the enterprise is in a passive.
Another director of drug companies even said angrily: "as a legal person, the enterprise can independently assume the legal responsibility, the legal status of the medical association."
The director questioned whether the medical association had the right to sign contracts with companies, as well as the legal effect of the contract.
Some drug companies for some place to carry out the second negotiation, head of the feeling is the main body of responsibilities unclear, against law, drug companies, the market value of negotiations, the main body of inequality, don't tell the difference only speak low.
When it comes to the "low price" bargaining approach, the head of a number of pharmaceutical companies said that there are fewer qualified products and many products have been squeezed out of the market.Corporate profits are constantly squeezed and lack of innovation.
The original intention of "second price negotiation" is to make the drug price more respectful to the market law. In the process of local implementation, enterprises are required to reduce the price difference and seem to deviate from the original intention of letting go of the second price.No wonder netizens have commented on the "geese and geese".
|
| |
Previous article：Strong grass-roots subsidies for the arrival of domestic medical standards to expand the market
Next article：122 primary hospitals in shaanxi province should purchase TCM diagnosis and treatment equipment
|
| |
|
|
